Who
Benjamin Shapiro
Director
Company insider
Files Form 4 as: Director, Oramed Pharmaceuticals.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 May 2023
- Last trade
- 31 Dec 2025
- Last filed
- 5 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Dec 2025filed 5 Jan 2026 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —3,500 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —3,500 | filing |
| 5 Jun 2025filed 9 Jun 2025 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 5 Jun 2025filed 9 Jun 2025 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —4,650 | filing |
| 4 Jan 2024filed 8 Jan 2024 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 4 Jan 2024filed 8 Jan 2024 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —5,070 | filing |
| 1 May 2023filed 1 May 2023 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —20,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.